Report #2842106

Received May 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 1 yrs
State: MO
Recovered: Unknown
Vaccinated: May 12, 2025
Onset: May 12, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEPA	HEP A (HAVRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	T9TL9	—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

Wrong age; Wrong dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult product administered to child in a 1-year-old male patient who received HAV (Havrix adult) (batch number T9TL9, expiry date 05-DEC-2025) for prophylaxis. On 12-MAY-2025, the patient received Havrix adult. On 12-MAY-2025, an unknown time after receiving Havrix adult, the patient experienced adult product administered to child (Verbatim: Wrong age) and overdose (Verbatim: Wrong dose). The outcome of the adult product administered to child and overdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 15-MAY-2025 Registered Nurse explained that a 1 year old patient received an adult dose of Havrix on May 12th 2025, which led to adult product administered to child and overdose.